Patents by Inventor Jimmy GOLLIHAR

Jimmy GOLLIHAR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240093285
    Abstract: Disclosed herein is a method of utilizing an enzyme in a nucleic acid manipulation process, the method comprising: a) transforming a microorganism with a non-native enzyme; b) inducing expression of the enzyme in the microorganism, thereby producing the non-native enzyme; c) adding the microorganism of step b) directly to a non-naturally occurring nucleic acid manipulation process, wherein the non-native enzyme is not purified from the microorganism prior to addition to the nucleic acid manipulation process; and carrying out the nucleic acid manipulation process using the enzyme. Importantly, this method can be carried out without the need to purify the enzyme from the cell producing it before it is used in the nucleic acid manipulation method. Also disclosed herein is a kit for carrying out a nucleic acid manipulation process, the kit comprising a) a microorganism expressing a non-native enzyme; b) nucleic acids of interest; and c) reagents for use in the nucleic acid manipulation process.
    Type: Application
    Filed: October 3, 2023
    Publication date: March 21, 2024
    Inventors: Andrew ELLINGTON, Sanchita BHADRA, Jared ELLEFSON, Jimmy GOLLIHAR, Arti POTHUKUCHY, Michelle BYROM, Raghav SHROFF
  • Patent number: 11912991
    Abstract: Embodiments of the disclosure concern methods and compositions related to generation and/or use of proofreading reverse transcriptases, including those that are thermophilic or hyperthermophilic. The disclosure encompasses specific recombinant polymerases and their use. In some embodiments, the polymerases are utilized for RNA sequencing in the absence of generation of a cDNA intermediate.
    Type: Grant
    Filed: November 13, 2020
    Date of Patent: February 27, 2024
    Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Andrew Ellington, Jared Ellefson, Jimmy Gollihar
  • Publication number: 20240043909
    Abstract: Disclosed herein are methods and platforms using Receptor Compartmentalized Partnered Replication (CPR), in which the partner gene is a receptor, signal transduction pathway, or metabolic pathway that leads to the production of an effector molecule for the receptor or signal transduction pathway. The signal transduction pathway or receptor is coupled to the production of a thermostable polymerase. Emulsification of libraries of organisms with primers that can amplify the partner gene led to the selective amplification of those partner genes that were best able to produce the thermostable polymerase during thermal cycling of the emulsion.
    Type: Application
    Filed: June 29, 2023
    Publication date: February 8, 2024
    Inventors: Andrew ELLINGTON, Jimmy GOLLIHAR, Katy KAO, Elizabeth GARDNER
  • Patent number: 11851699
    Abstract: Disclosed are methods for isothermal nucleic acid amplification and detection.
    Type: Grant
    Filed: February 5, 2021
    Date of Patent: December 26, 2023
    Assignee: Board of Regents, The University of Texas System
    Inventors: Andrew Ellington, Yu Sherry Jiang, Sanchita Bhadra, Bingling Li, Randy Allen Hughes, Yan Du, Jimmy Gollihar
  • Patent number: 11807901
    Abstract: Disclosed herein is a method of utilizing an enzyme in a nucleic acid manipulation process, the method comprising: a) transforming a microorganism with a non-native enzyme; b) inducing expression of the enzyme in the microorganism, thereby producing the non-native enzyme; c) adding the microorganism of step b) directly to a non-naturally occurring nucleic acid manipulation process, wherein the non-native enzyme is not purified from the microorganism prior to addition to the nucleic acid manipulation process; and carrying out the nucleic acid manipulation process using the enzyme. Importantly, this method can be carried out without the need to purify the enzyme from the cell producing it before it is used in the nucleic acid manipulation method. Also disclosed herein is a kit for carrying out a nucleic acid manipulation process, the kit comprising a) a microorganism expressing a non-native enzyme; b) nucleic acids of interest; and c) reagents for use in the nucleic acid manipulation process.
    Type: Grant
    Filed: November 15, 2018
    Date of Patent: November 7, 2023
    Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Andrew Ellington, Sanchita Bhadra, Jared Ellefson, Jimmy Gollihar, Arti Pothukuchy, Michelle Byrom, Raghav Shroff
  • Patent number: 11746374
    Abstract: Disclosed herein are methods and platforms using Receptor Compartmentalized Partnered Replication (CPR), in which the partner gene is a receptor, signal transduction pathway, or metabolic pathway that leads to the production of an effector molecule for the receptor or signal transduction pathway. The signal transduction pathway or receptor is coupled to the production of a thermostable polymerase. Emulsification of libraries of organisms with primers that can amplify the partner gene led to the selective amplification of those partner genes that were best able to produce the thermostable polymerase during thermal cycling of the emulsion.
    Type: Grant
    Filed: June 15, 2018
    Date of Patent: September 5, 2023
    Assignees: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM, THE TEXAS A&M UNIVERSITY
    Inventors: Andrew Ellington, Jimmy Gollihar, Katy Kao, Elizabeth Gardner
  • Publication number: 20210403979
    Abstract: Disclosed are methods for isothermal nucleic acid amplification and detection.
    Type: Application
    Filed: February 5, 2021
    Publication date: December 30, 2021
    Inventors: Andrew Ellington, Yu Sherry Jiang, Sanchita Bhadra, Bingling Li, Randy Allen Hughes, Yan Du, Jimmy Gollihar
  • Publication number: 20210301321
    Abstract: Disclosed are methods for isothermal nucleic acid amplification and detection.
    Type: Application
    Filed: March 23, 2021
    Publication date: September 30, 2021
    Inventors: Andrew Ellington, Yu Sherry Jiang, Sanchita Bhadra, Bingling Li, Randy Allen Hughes, Yan Du, Jimmy Gollihar
  • Publication number: 20210130816
    Abstract: Embodiments of the disclosure concern methods and compositions related to generation and/or use of proofreading reverse transcriptases, including those that are thermophilic or hyperthermophilic. The disclosure encompasses specific recombinant polymerases and their use. In some embodiments, the polymerases are utilized for RNA sequencing in the absence of generation of a cDNA intermediate.
    Type: Application
    Filed: November 13, 2020
    Publication date: May 6, 2021
    Inventors: Andrew ELLINGTON, Jared ELLEFSON, Jimmy GOLLIHAR
  • Patent number: 10913973
    Abstract: Disclosed are compositions and methods for isothermal nucleic acid amplification and detection.
    Type: Grant
    Filed: September 17, 2015
    Date of Patent: February 9, 2021
    Assignee: Board of Regents, The University Texas System
    Inventors: Andrew Ellington, Yu Sherry Jiang, Sanchita Bhadra, Bingling Li, Randy Allen Hughes, Yan Du, Jimmy Gollihar
  • Publication number: 20200399679
    Abstract: Disclosed herein is a method of utilizing an enzyme in a nucleic acid manipulation process, the method comprising: a) transforming a microorganism with a non-native enzyme; b) inducing expression of the enzyme in the microorganism, thereby producing the non-native enzyme; c) adding the microorganism of step b) directly to a non-naturally occurring nucleic acid manipulation process, wherein the non-native enzyme is not purified from the microorganism prior to addition to the nucleic acid manipulation process; and carrying out the nucleic acid manipulation process using the enzyme. Importantly, this method can be carried out without the need to purify the enzyme from the cell producing it before it is used in the nucleic acid manipulation method. Also disclosed herein is a kit for carrying out a nucleic acid manipulation process, the kit comprising a) a microorganism expressing a non-native enzyme; b) nucleic acids of interest; and c) reagents for use in the nucleic acid manipulation process.
    Type: Application
    Filed: November 15, 2018
    Publication date: December 24, 2020
    Inventors: Andrew ELLINGTON, Sanchita BHADRA, Jared ELLEFSON, Jimmy GOLLIHAR, Arti POTHUKUCHY, Michelle BYROM, Raghav SHROFF
  • Patent number: 10858652
    Abstract: Embodiments of the disclosure concern methods and compositions related to generation and/or use of proofreading reverse transcriptases, including those that are thermophilic or hyperthermophilic. The disclosure encompasses specific recombinant polymerases and their use. In some embodiments, the polymerases are utilized for RNA sequencing in the absence of generation of a cDNA intermediate.
    Type: Grant
    Filed: May 8, 2019
    Date of Patent: December 8, 2020
    Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Andrew Ellington, Jared Ellefson, Jimmy Gollihar
  • Publication number: 20200208201
    Abstract: Disclosed herein are methods and platforms using Receptor Compartmentalized Partnered Replication (CPR), in which the partner gene is a receptor, signal transduction pathway, or metabolic pathway that leads to the production of an effector molecule for the receptor or signal transduction pathway. The signal transduction pathway or receptor is coupled to the production of a thermostable polymerase. Emulsification of libraries of organisms with primers that can amplify the partner gene led to the selective amplification of those partner genes that were best able to produce the thermostable polymerase during thermal cycling of the emulsion.
    Type: Application
    Filed: June 15, 2018
    Publication date: July 2, 2020
    Inventors: Andrew ELLINGTON, Jimmy GOLLIHAR, Katy KAO, Elizabeth GARDNER
  • Publication number: 20190376059
    Abstract: Embodiments of the disclosure concern methods and compositions related to generation and/or use of proofreading reverse transcriptases, including those that are thermophilic or hyperthermophilic. The disclosure encompasses specific recombinant polymerases and their use. In some embodiments, the polymerases are utilized for RNA sequencing in the absence of generation of a cDNA intermediate.
    Type: Application
    Filed: May 8, 2019
    Publication date: December 12, 2019
    Inventors: Andrew ELLINGTON, Jared ELLEFSON, Jimmy GOLLIHAR
  • Patent number: 10323243
    Abstract: Embodiments of the disclosure concern methods and compositions related to generation and/or use of proofreading reverse transcriptases, including those that are thermophilic or hyperthermophilic. The disclosure encompasses specific recombinant polymerases and their use. In some embodiments, the polymerases are utilized for RNA sequencing in the absence of generation of a cDNA intermediate.
    Type: Grant
    Filed: January 19, 2017
    Date of Patent: June 18, 2019
    Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Andrew Ellington, Jared Ellefson, Jimmy Gollihar
  • Publication number: 20170327818
    Abstract: Embodiments of the disclosure concern methods and compositions related to generation and/or use of proofreading reverse transcriptases, including those that are thermophilic or hyperthermophilic. The disclosure encompasses specific recombinant polymerases and their use. In some embodiments, the polymerases are utilized for RNA sequencing in the absence of generation of a cDNA intermediate.
    Type: Application
    Filed: January 19, 2017
    Publication date: November 16, 2017
    Inventors: Andrew ELLINGTON, Jared ELLEFSON, Jimmy GOLLIHAR